How about this. The Sun poster is titled exactly as the original CTAD 2015 abstract, but with the added 'Dose Dependent'. I surmised last year that the CTAD presentation appeared as though some slides were removed, leaving the one (#18 I think) for the only 12 week mark. Sunday's poster may be the full presentation of this 12 week data that they decided not to reveal until further analysis and 26 week results could assure that "there can be no doubt as to the cause-effect relationship of the 12-week efficacy data". That conforms to Occam's Razor.
Wednesday will be a full 26 week readout and AE report concluding that 'Results warrant advancing A2-73 into P2/3'. No 'CURE!'
Missling will present orally at 5:30 on how mixed sigma-1/Mx compounds, when administered in chronic, low-dose combo formulation to early-onset patients may actually halt the progression of the disease. He is far too polite to drop the mic. ;-)
Then it's cocktail hour...as usual. :-)
§
News 
Market Data 
Discover 
